Home › Atrial Fibrillation › Florida › Clearwater
Atrial Fibrillation clinical trials in Clearwater, FL
5 studies for Atrial Fibrillation are looking for participants at sites in and around Clearwater (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- BayCare Health Systems, Clearwater
BoxX-NoAF Clinical Trial
RecruitingHealthy volunteers welcome
- Morton Plant Hospital - BayCare Health System, Inc., Clearwater
- St. Joseph's Hospital - BayCare Health System, Inc., Clearwater
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
RecruitingPhase 3
- Anthos Investigational site 9818, Clearwater
- Anthos Investigative Site 1025, Clearwater
- Anthos Investigative Site 1022, Clearwater
- and 1 more
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Morton Plant Hospital, Clearwater
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Recruiting
- BayCare Health System, Clearwater
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- Boston, MA19 studies
- New York City, NY19 studies
- Atlanta, GA17 studies
- Cleveland, OH17 studies
- Jonesboro, AR13 studies
- Pittsburgh, PA12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI12 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Cincinnati, OH10 studies
- Austin, TX10 studies
Other studies in Clearwater
- Cardiovascular Disease9 studies
- Lupus7 studies
- Obesity7 studies
- Overweight6 studies
- Heart Failure6 studies
- Breast Cancer6 studies
- Coronary Artery Disease5 studies
- Rheumatoid Arthritis5 studies
- Non-Small Cell Lung Cancer5 studies
- Sjögren's Disease4 studies
- Lung Cancer4 studies
- Type 2 Diabetes4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.